Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial.
Meattini I, Saieva C, Marrazzo L, Di Brina L, Pallotta S, Mangoni M, Meacci F, Bendinelli B, Francolini G, Desideri I, De Luca Cardillo C, Scotti V, Furfaro IF, Rossi F, Greto D, Bonomo P, Casella D, Bernini M, Sanchez L, Orzalesi L, Simoncini R, Nori J, Bianchi S, Livi L. Meattini I, et al. Among authors: furfaro if. Breast Cancer Res Treat. 2015 Oct;153(3):539-47. doi: 10.1007/s10549-015-3565-2. Epub 2015 Sep 9. Breast Cancer Res Treat. 2015. PMID: 26350524 Clinical Trial.
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer.
Meattini I, Francolini G, Scotti V, De Luca Cardillo C, Cappelli S, Meacci F, Furfaro IF, Muntoni C, Scoccianti S, Detti B, Mangoni M, Nori J, Orzalesi L, Fambrini M, Bianchi S, Livi L. Meattini I, et al. Among authors: furfaro if. Med Oncol. 2015 Mar;32(3):80. doi: 10.1007/s12032-015-0535-9. Epub 2015 Feb 20. Med Oncol. 2015. PMID: 25698536 Clinical Trial.
Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice.
Scoccianti S, Detti B, Gadda D, Greto D, Furfaro I, Meacci F, Simontacchi G, Di Brina L, Bonomo P, Giacomelli I, Meattini I, Mangoni M, Cappelli S, Cassani S, Talamonti C, Bordi L, Livi L. Scoccianti S, et al. Radiother Oncol. 2015 Feb;114(2):230-8. doi: 10.1016/j.radonc.2015.01.016. Epub 2015 Feb 17. Radiother Oncol. 2015. PMID: 25701297
Docetaxel in castration-resistant prostate cancer: a single-centre experience.
Detti B, Franceschini D, Saieva C, Di Brina L, Baki M, Meattini I, Di Cataldo V, Pasquetti EM, Furfaro I, Mancuso A, Simontacchi G, Livi L. Detti B, et al. Cancer Invest. 2014 Nov;32(9):445-50. doi: 10.3109/07357907.2014.958233. Epub 2014 Sep 26. Cancer Invest. 2014. PMID: 25259606
Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience.
Detti B, Franceschini D, Saieva C, Di Brina L, Baki M, Meattini I, Di Cataldo V, Pasquetti EM, Furfaro I, Mancuso A, Simontacchi G, Livi L. Detti B, et al. Cancer Invest. 2015;33(7):329. doi: 10.3109/07357907.2015.1060063. Epub 2015 Jul 2. Cancer Invest. 2015. PMID: 26135542 No abstract available.
11 results